Invention Grant
US08128920B2 Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
有权
使用IL-18BP同种型治疗和/或预防神经性炎症性疾病
- Patent Title: Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
- Patent Title (中): 使用IL-18BP同种型治疗和/或预防神经性炎症性疾病
-
Application No.: US11915913Application Date: 2006-06-02
-
Publication No.: US08128920B2Publication Date: 2012-03-06
- Inventor: Yves Sagot , Yolande Chvatchko , Anne Corbaz
- Applicant: Yves Sagot , Yolande Chvatchko , Anne Corbaz
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP05104863 20050603
- International Application: PCT/EP2006/062864 WO 20060602
- International Announcement: WO2006/128911 WO 20061207
- Main IPC: A61K31/395
- IPC: A61K31/395 ; A61K38/17 ; A61K38/20
Abstract:
The invention relates to the use of an IL18-BP isoform that does not bind to IL18, or of an agonist thereof, for treatment or prevention of a neurological and/or inflammatory disease. Preferred isoforms for use in the frame of the invention include IL-18BPb and IL-18BPd.
Public/Granted literature
- US20080233085A1 Use of Il-18Bp Isoforms for the Treatment and/or Prevention of Neurological Inflammatory Diseases Public/Granted day:2008-09-25
Information query
